摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-phenyl-4,5,6,7-tetrahydro-1H-1,3-diazepine | 76894-37-6

中文名称
——
中文别名
——
英文名称
2-phenyl-4,5,6,7-tetrahydro-1H-1,3-diazepine
英文别名
2-phenyl-1,3-diazacycloheptene;2-phenyl-2,7-diazacycloheptene;2-phenyl-4,5,6,7-tetrahydro-1H-[1,3]diazepine;2-Phenyl-4,5,6,7-tetrahydro-1H-[1,3]diazepin;4,5,6,7-Tetrahydro-2-phenyl-1H-1,3-diazepine
2-phenyl-4,5,6,7-tetrahydro-1H-1,3-diazepine化学式
CAS
76894-37-6
化学式
C11H14N2
mdl
——
分子量
174.246
InChiKey
YPSSKZYWAMIXNE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    329.7±15.0 °C(Predicted)
  • 密度:
    1.07±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    24.4
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    2-phenyl-4,5,6,7-tetrahydro-1H-1,3-diazepine乙醇 为溶剂, 反应 60.0h, 以95%的产率得到N-(4-氨基丁基)苯甲酰胺
    参考文献:
    名称:
    碱性,亲脂性,并且受体的缺乏相互作用Ñ -Aminoalkylbenzamides和Ñ -Aminoalkyl- ö -anisamides作为多巴胺拮抗剂的模型化合物
    摘要:
    Ñ -Aminoalkylbenzamides和Ñ -aminoalkyl- ö -methoxybenzamides已经制备并检测它们的p ķ一个,登录P和多巴胺受体的亲和性。p K a值的范围从ca。对于具有一个-C原子侧链的衍生物,为约7.5 。10.3为N-氨基丁基衍生物。链长的这些变化可以通过现场模型得到令人满意的解释。(log P)值的变化作为链长和N原子取代的函数,表明存在邻近和构象效应。化合物完全不能取代来自其特定的大鼠纹状体结合位点的3 H-哌啶酮和3 H-磺胺必隆证明了在位置4和5进行足够的芳族取代的关键作用。
    DOI:
    10.1002/hlca.19830660215
  • 作为产物:
    描述:
    苯甲酸酐 在 bis(triphenyl)oxodiphosphonium trifluoromethanesulfonate salt 作用下, 以 二氯甲烷 为溶剂, 反应 36.08h, 生成 2-phenyl-4,5,6,7-tetrahydro-1H-1,3-diazepine
    参考文献:
    名称:
    Cyclodehydration of N-(Aminoalkyl)benzamides under Mild Conditions with a Hendrickson Reagent Analogue
    摘要:
    Methods for the cydodehydration of N-(aminoalkyl)benzamides are few and employ harsh reaction conditions. We have found that the easily prepared phosphonium anhydrides 1 (Hendrickson reagent) or 2 can be used for cyclodehydration of N-(aminoalkyl)benzamides under very mild conditions (room temperature) to produce five-, six-, and seven-membered cyclic amidines. Good yields are obtained by employing a temporary trityl group protection strategy. Cyclic analogue 2 can be used when the product cyclic amidine is organic-soluble, thus producing water-soluble byproducts.
    DOI:
    10.1021/jo401082q
点击查看最新优质反应信息

文献信息

  • Use of lanthanide(III) ions as catalysts for the reactions of amines with nitriles
    作者:John H. Forsberg、Vincent T. Spaziano、Trichey M. Balasubramanian、Gordon K. Liu、Steven A. Kinsley、Charles A. Duckworth、John J. Poteruca、Paul S. Brown、Judith L. Miller
    DOI:10.1021/jo00382a009
    日期:1987.3
  • 96. Amidines. Part VI. Preparation of 2-substituted 4 : 5-dihydroglyoxalines and ring homologues from cyanides and alkylenediamines
    作者:P. Oxley、W. F. Short
    DOI:10.1039/jr9470000497
    日期:——
查看更多

同类化合物

雷唑巴占 唑美巴占 六氢-2-(硝基亚氨基)-1H-1,3-二氮杂卓 [1,3]恶唑并[3,2-a][1,3]二氮杂卓 7-苯基-3,4-二氢-1H-1,4-二氮杂革-5(2H)-酮 7,8-二氢-1-苯基-6H-吡啶并(3,2,1-jk)(1,4)苯并二氮杂卓-4(3H)-酮 5H-吡咯并[1,2-a][1,4]二氮杂卓 5-甲基-7-苯基-6,7-二氢-1H-1,4-二氮杂-2,3-二甲腈 5-三氟甲基-2,3-二氢-1H-1,4-二氮杂卓 5,7-二苯基-2,3,6,7-四氢-1H-1,4-二氮杂卓 5,7-二甲基-2,3-二氢-1H-[1,4]二氮杂卓高氯酸盐 5,7-二甲基-2,3,5,6-四氢-1H-环戊二烯并[b]吡嗪 4,5,6,7-四氢-1H-1,3-二氮杂卓-2-胺 3,5,7-三苯基-4H-1,2-二氮杂卓 2H-[1,3,5]恶二嗪o[3,2-a][1,3]二氮杂卓 2-甲基硫代-4,5,6,7-四氢-1H-[1,3]二氮杂卓 2-甲基-4,5,6,7-四氢-1H-1,3-二氮杂卓 2,3-二氢-5-甲基-7-三氟甲基-1H-1,4-二氮杂卓 2,3-二氢-5,7-双(三氟甲基)-1H-1,4-二氮杂卓 1-(5-甲氧基-1,4-二氮杂-1-基)乙酮 1,4,5,7,8,9,10,10A-八氢吡啶并[1,2-a][1,4]二氮杂卓 (9ci)-2,3-二氢-N,N-二甲基-1H-1,4-二氮杂卓-6-甲胺 (9ci)-1H-1,2-二氮杂卓-1-羧酸甲酯 (9ci)-1H,3h-噁唑并[3,4-d][1,4]二氮杂卓 (9ci)-1H,3h-噁唑并[3,4-a][1,4]二氮杂卓 8-Phenyl-2,3,6,7-tetrahydro-4H-1,4-diazocin-5-on 1,3-diphenyl-1,2-dihydro-pyridazino[3,4-b]quinoxaline 3-(4-Bromphenyl)-5,6,7,8-tetrahydro-thiazolo<3,2-a>-<1,3>diazepin 2,3-Dihydro-5-methyl-1,4-diazepin 3-Methyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a][1,3]diazepine 2,4,10,12,18,20-hexamethyl-1,5,9,13,17,21-hexaaza-cyclotetracosa-1,3,9,11,17,19-hexaene 2-(2-benzylidene-3-((4-methylbenzylidene)hydrazineylidene)-2,3,6,7,8,9-hexahydro-5H-thiazolo[2,3-b]quinazolin-5-yl)phenol 3,11-diphenyl-1,5,9,13-tetraaza-cyclohexadeca-1,3,9,11-tetraene 7,10-dichloro-4-[4-(1,1-difluoroethyl)phenyl]-5,6-dihydro-4H-pyrrolo[1,2-a][1,4]-benzodiazepine hydrochloride 7-bromo-5,6-dihydro-2,3-dimethylpyrido<2,3-b>pyrazine 7-(3-Chloro-4-fluoro-phenyl)-5-trifluoromethyl-2,3-dihydro-1H-[1,4]diazepine 6,14-diphenyl-1,4,8,12-tetraaza-cyclopentadeca-4,6,12,14-tetraene 6,13-diphenyl-1,4,8,11-tetraaza-cyclotetradeca-4,6,11,13-tetraene 7-(3-Chloro-4-fluoro-phenyl)-5-phenyl-2,3-dihydro-1H-[1,4]diazepine 7-(4-Fluoro-phenyl)-5-methyl-2,3-dihydro-1H-[1,4]diazepine 3-(7-methyl-5-oxo-4,5-dihydro-2H-pyrazolo[1,5-a]pyrimidin-1-yl)-but-2-enenitrile 7-(2-Fluoro-5-methyl-phenyl)-5-methyl-2,3-dihydro-1H-[1,4]diazepine trans-diazido(2,3,9,10-tetramethyl-1,4,8,11-tetra-azacyclotetradeca-1,3,8,10-tetraene)cobalt(III) perchlorate 2,2-dimethyl-2,6,7,8-tetrahydro-3H-pyrrolo[1,2-a]pyrimidin-4-one ethyl 4-acetamidodiazepine-1-carboxylate 5,7-dimethyl-4,5,6,7-tetrahydro-1H-[1,4]diazepine-2,3-dicarbonitrile 1,4,8,11-Tetraazacyclotetradeca-4,6,11,13-tetraene,5,7,12,14-tetramethyl- 5,6,6,7a-tetramethyl-3-phenyl-5,6,7,7a-tetrahydro-pyrazolo[1,5-d][1,2,4]oxadiazole